Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Sep 14, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | NYSE | Drug Manufacturers - General | A | $714.94B | $755.39 | -0.12% | $18.75B | 49.21x | 4.52 | United States | 65 |
| RYAAY | RYANAIR HOLDINGS PLC | NASDAQ | Airlines | A | $31.21B | $58.68 | -1.91% | $3.44B | 17.85x | 1.49 | Ireland | 37 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | A | $10.39B | $54.09 | -3.26% | $934.37M | 15.72x | 0.24 | United States | 73 |
| RRX | REGAL REXNORD CORP | NYSE | Specialty Industrial Machinery | A | $9.22B | $138.86 | -4.19% | $1.21B | 36.83x | 1.07 | United States | 35 |
| BGC | BGC GROUP INC | NASDAQ | Capital Markets | A | $4.82B | $10.17 | -0.39% | $404.32M | 32.81x | 4.07 | United States | 45 |
| IHS | IHS HOLDING LTD | NYSE | Telecom Services | A | $2.55B | $7.61 | 3.82% | N/A | 22.38x | -16.94 | United Kingdom | 25 |
| DBD | DIEBOLD NIXDORF INC | NYSE | Software - Application | A | $2.17B | $59.26 | -2.08% | $275.40M | -174.29x | 2.40 | United States | 17 |
| FIVN | FIVE9 INC | NASDAQ | Software - Infrastructure | A | $2.00B | $25.84 | -1.00% | $98.42M | 198.77x | 1.38 | United States | 46 |
| ARDT | ARDENT HEALTH PARTNERS INC | NYSE | Medical Care Facilities | A | $1.87B | $13.08 | -1.43% | $541.00M | 7.03x | 2.70 | United States | 48 |
| NTCT | NETSCOUT SYSTEMS INC | NASDAQ | Software - Infrastructure | A | $1.79B | $25.10 | -2.71% | -$294.85M | -4.90x | 0.40 | United States | 28 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $1.66B | $7.91 | -1.98% | $63.44M | -43.94x | -2.08 | United States | 12 |
| AVDL | AVADEL PHARMACEUTICALS PLC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $1.50B | $15.40 | -2.90% | $7.86M | -513.33x | 1.06 | Ireland | 35 |
| GBX | GREENBRIER COMPANIES INC | NYSE | Railroads | A | $1.42B | $46.14 | -2.23% | $541.60M | 6.29x | 1.78 | United States | 34 |
| DCO | DUCOMMUN INC | NYSE | Aerospace & Defense | A | $1.38B | $93.03 | -0.20% | $98.47M | 39.25x | 0.63 | United States | 43 |
| LMB | LIMBACH HOLDINGS INC | NASDAQ | Engineering & Construction | A | $1.23B | $105.93 | 2.60% | $63.54M | 34.17x | 1.01 | United States | 61 |
| EVER | EVERQUOTE INC | NASDAQ | Internet Content & Information | A | $895.66M | $24.53 | -0.77% | $54.06M | 18.87x | 0.42 | United States | 54 |
| NRDS | NERDWALLET INC | NASDAQ | Internet Content & Information | A | $786.11M | $10.55 | -1.40% | $51.20M | 27.05x | 0.28 | United States | 55 |
| TBPH | THERAVANCE BIOPHARMA INC | NASDAQ | Biotechnology | A | $720.17M | $14.30 | 4.38% | $48.42M | 57.20x | 0.90 | Cayman Islands | 39 |
| LYTS | LSI INDUSTRIES INC | NASDAQ | Electronic Components | A | $685.61M | $22.47 | -1.83% | $48.74M | 27.40x | 0.72 | United States | 56 |
| KMDA | KAMADA LTD | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $403.69M | $7.02 | 0.07% | $34.21M | 21.27x | 0.42 | Israel | 51 |
| NATR | NATURES SUNSHINE PRODUCTS INC | NASDAQ | Packaged Foods | A | $299.10M | $16.96 | -0.47% | $43.34M | 22.03x | 0.56 | United States | 36 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $204.06M | $9.99 | -1.38% | $23.52M | 43.43x | 0.85 | United States | 29 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $199.38M | $23.88 | -4.71% | $11.32M | 26.83x | 0.25 | United States | 44 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.